참고문헌
- Ardekani AM, Akhondi MM, Sadeghi MR (2008). Application of genomic and proteomic technologies to early detection of cancer. Arch Iran Med, 11, 427-34.
- Bai Z, Ye Y, Liang B, et al (2011). Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer. Int J Oncol, 38: 375-83.
- Baker ES, Liu T, Petyuk VA, et al (2012). Mass spectrometry for translational proteomics: progress and clinical implications. Genome Med, 4, 1-11. https://doi.org/10.1186/gm300
- Bhati A, Garg H, Gupta A, et al (2012). Omics of cancer. Asian Pac J Cancer Prev, 13, 4229-33. https://doi.org/10.7314/APJCP.2012.13.9.4229
- Boja ES, Rodriguez H (2012). Mass spectrometry based targeted quantitative proteomics: Achieving sensitive and reproducible detection of proteins. Proteomics, 12, 1093-110. https://doi.org/10.1002/pmic.201100387
- Brower V (2011). Epigenetics: Unravelling the cancer code. Nature, 471, 12-3. https://doi.org/10.1038/471S12a
- Cao Y, DePinho RA, Ernst M, Vousden (2011). Cancer research: past, present and future. Nat Rev Cancer, 11, 749-54. https://doi.org/10.1038/nrc3138
- Castronovo V, Kischel P, Guillonneau F, et al (2007). Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method. Proteomics, 7, 1188-96. https://doi.org/10.1002/pmic.200600888
- Chandra H, Reddy PJ, Srivastava S (2011). Protein microarrays and novel detection platforms. Expert Rev Proteomics, 8, 61-79. https://doi.org/10.1586/epr.10.99
- Chang R, Shoemaker R, Wang W (2011). Systematic search for recipes to generate induced pluripotent stem cells. PLoS Comput Biol, 7, 1002300. https://doi.org/10.1371/journal.pcbi.1002300
- Coghlin C, Murray GI (2013). Progress in the identification of plasma biomarkers of colorectal cancer. Proteomics, 13 2227-8. https://doi.org/10.1002/pmic.201300245
- Collins BC, Lau TY, O'Connor DP, Hondermarck H (2009). Cancer proteomics-an evolving battlefield. Conference on Cancer Proteomics 2009: Mechanistic Insights, Technological Advances & Molecular Medicine. EMBO reports, 10, 1202-5. https://doi.org/10.1038/embor.2009.222
- Edwards BK, Ward E, Kohler BA, et al (2010). Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer, 116, 544-73. https://doi.org/10.1002/cncr.24760
- Etzioni R, Urban N, Ramsey S, et al (2003). The case for early detection. Nat Rev Cancer, 3, 243-52. https://doi.org/10.1038/nrc1041
- Fan Y, Wang J, Yang Y, et al (2010). Detection and identification of potential biomarkers of breast cancer. J Cancer Res Clin Oncol, 136, 1243-54. https://doi.org/10.1007/s00432-010-0775-1
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
- Ferrari M (2005). Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer, 5, 161-71. https://doi.org/10.1038/nrc1566
- Fujita Y, Nakanishi T, Hiramatsu M, et al (2006). Proteomicsbased approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma. Clin Cancer Res, 12, 6415-20. https://doi.org/10.1158/1078-0432.CCR-06-1315
- Ghabaee M, Bayati A, Amir Saroukolaei, et al (2009). Analysis of HLA DR2&DQ6 (DRB1* 1501, DQA1* 0102, DQB1* 0602) haplotypes in Iranian patients with multiple sclerosis. Cell Mol Neurobiol, 29, 109-14. https://doi.org/10.1007/s10571-008-9302-1
- Gold L, Ayers D, Bertino J, et al (2010). Aptamer-based multiplexed proteomic technology for biomarker discovery. PloS One, 5, 15004. https://doi.org/10.1371/journal.pone.0015004
- Goncalves A, Charafe-Jauffret E, Bertucci F, et al (2008). Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes. Mol Cell Proteomics, 7, 1420-33. https://doi.org/10.1074/mcp.M700487-MCP200
- Gortzak-Uzan L, Ignatchenko A, Evangelou Al, et al (2007). A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers. J Proteome Res, 7, 339-51.
- Gray J, Chattopadhyay D, Beale GS, et al (2009). A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. BMC Cancer, 9, 271. https://doi.org/10.1186/1471-2407-9-271
- Gstaiger M, Aebersold R (2009). Applying mass spectrometrybased proteomics to genetics, genomics and network biology. Nat Rev Genet, 10, 617-27. https://doi.org/10.1038/nrg2633
- Hainaut P, Plymoth A (2011). Biomarkers in cancer research and treatment: promises and challenges. Curr Opin Oncol, 23, 61. https://doi.org/10.1097/CCO.0b013e328341623e
- Hanash SM, Baik CS, Kallioniemi O (2011). Emerging molecular biomarkers-blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol, 8, 142-50. https://doi.org/10.1038/nrclinonc.2010.220
- Hanash SM, Pitteri SJ, Faca VM (2008). Mining the plasma proteome for cancer biomarkers. Nature, 452, 571-9. https://doi.org/10.1038/nature06916
- Hatakeyama H, Kondo T, et al (2006). Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics, 6, 6300-16. https://doi.org/10.1002/pmic.200600488
-
Hooshmand S, Ghaderi A, Yusoff K, et al (2013). Downregulation of RhoGDI
$\alpha$ increased migration and invasion of ER+MCF7 and ER? MDA-MB-231 breast cancer cells. Cell Adh Migr, 7, 297-303. https://doi.org/10.4161/cam.24204 - International Cancer Genome Consortium, Hudson TJ, Anderson W, et al (2010). International network of cancer genome projects. Nature, 464, 993-8. https://doi.org/10.1038/nature08987
- IBM Corp. Released 2011. IBM SPSS Statistics for Windows, V. A., NY: IBM Corp.
- Jacquemier J, Ginestier C, Rougemount J, et al (2005). Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Res, 65, 767-79.
- Jazii FR, Najafi Z, Malekzadeh R, et al (2006). Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. World J Gastroenterol, 12, 7104-12.
- Kamangar F, Karimi P (2013). The state of nutritional epidemiology: why we are still unsure of what we should eat?. Arch Iran Med, 16, 483-6.
- Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F (2014). Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev, In Press.
- Karimi P, Modarresi SZ, Sahraian MA, et al (2013). The relation of multiple sclerosis with allergy and atopy: a case control study. Iran J Allergy Asthma Immunol, 12, 182-9.
- Karimi P, Shahrokni A, Moradi S (2013). Evidence for U.S. Preventive Services Task Force (USPSTF) Recommendations against routine mammography for females between 40-49 years of age. Asian Pac J Cancer Prev, 14, 2137-9. https://doi.org/10.7314/APJCP.2013.14.3.2137
- Kent W J, Sugnet CW, Furey TS, et al (2002). The human genome browser at UCSC. Genome Res, 12, 996-1006. https://doi.org/10.1101/gr.229102.ArticlepublishedonlinebeforeprintinMay2002
- Kocevar N, Odreman F, Vindigni A, Grazio SF, Komel R (2012). Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers. World J Gastroenterol, 18, 1216-28. https://doi.org/10.3748/wjg.v18.i11.1216
- Li G, Xiao Z, Liu J, et al (2011). Cancer: a proteomic disease. Sci China Life Sci, 54, 403-8.
- Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002). Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem, 48, 1296-304.
- Lopez E, Wesselink JJ, Lopez I, et al (2011). Technical phosphoproteomic and bioinformatic tools useful in cancer research. J Clin Bioinforma, 1, 26. https://doi.org/10.1186/2043-9113-1-26
- Martin KJ, Fournier MV, Reddy GP, Pardee AB (2010). A need for basic research on fluid-based early detection biomarkers. Cancer Res, 70, 5203-6. https://doi.org/10.1158/0008-5472.CAN-10-0987
- Maurer HH (2010). Perspectives of liquid chromatography coupled to low-and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Ther Drug Monit, 32, 324-7. https://doi.org/10.1097/FTD.0b013e3181dca295
- Mishra A, Verma M (2010). Cancer biomarkers: are we ready for the prime time? Cancers, 2, 190-208. https://doi.org/10.3390/cancers2010190
- Moghanibashi M, Jazii FR, Soheili ZS, et al (2012). Proteomics of a new esophageal cancer cell line established from Persian patient. Gene, 500, 124-33. https://doi.org/10.1016/j.gene.2012.03.038
- Moghanibashi M, Rastgar Jazii F, Soheili ZS, et al (2013). Esophageal cancer alters the expression of nuclear pore complex binding protein Hsc70 and eIF5A-1. Funct Integr Genomics, 13, 253-60. https://doi.org/10.1007/s10142-013-0320-9
- Montazery-Kordy H, Miran-Baygi MH, Moradi MH (2008). A data-mining approach to biomarker identification from protein profiles using discrete stationary wavelet transform. J Zhejiang Univ Sci B, 9, 863-70. https://doi.org/10.1631/jzus.B0820163
- Nezami Ranjbar MR, Zhao Y, Tadesse MG, Wang Y, Ressom HW (2013) Gaussian process regression model for mormalization of LC-MS data using scan-level information. Proteome Sci, 11, 13. https://doi.org/10.1186/1477-5956-11-13
- Nicolini C, Pechkova E (2010). An overview of nanotechnologybased functional proteomics for cancer and cell cycle progression. Anticancer Res, 30, 2073-80.
- Orvisky ES, Drake K, Martin BM, et al (2006). Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. Proteomics, 6, 2895-902. https://doi.org/10.1002/pmic.200500443
- Pei H, Zhu H, Zeng S, et al (2007). Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res, 6, 2495-501. https://doi.org/10.1021/pr060644r
- Pepe MS, Etzioni R, Feng Z, et al (2001). Phases of biomarker development for early detection of cancer. J Natl Cancer Inst, 93, 1054-61. https://doi.org/10.1093/jnci/93.14.1054
- Poste G (2012). Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards. Trends Mol Med, 18, 717-22. https://doi.org/10.1016/j.molmed.2012.09.003
- Rahman SM, Gonzalez AL Li M, et al (2011). Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Cancer Res, 71, 3009-17. https://doi.org/10.1158/0008-5472.CAN-10-2510
- Ransohoff DF, Gourlay ML (2010). Sources of bias in specimens for research about molecular markers for cancer. J Clin Oncol, 28, 698-704. https://doi.org/10.1200/JCO.2009.25.6065
- Ray S, Reddy PJ, Jain R, et al (2011). Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics, 11, 2139-61. https://doi.org/10.1002/pmic.201000460
- Ressom HW, Xiao JF Tuli L, et al (2012). Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. Anal Chim Acta, 19, 90-100.
- Rezaee AR, Azadi A, Houshmand M, et al (2013). Mitochondrial and nuclear genes as the cause of complex I deficiency. Genet Mol Res, 12, 3551-4. https://doi.org/10.4238/2013.September.12.1
- Rual JF, Venkatesan K, Hao T, et al (2005). Towards a proteomescale map of the human protein-protein interaction network. Nature, 437, 1173-8. https://doi.org/10.1038/nature04209
- Rusling JF, Kumar CV, Gutkind JS, et al (2010). Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. Analyst, 135, 2496-511. https://doi.org/10.1039/c0an00204f
- Sadat Tabatabaei Mirakabad F, Nejati-Koshki K, Akbarzadeh A, et al (2014) PLGA-Based nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev, 15, 517-35. https://doi.org/10.7314/APJCP.2014.15.2.517
- Shahrokni A, Karimi P (2012). Geriatric assessment in geriatric oncology; the evolution of authors' network from 2000 to 2012. J Geriatr Oncol, 3, 78-9.
- Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
- Smith RA, Cokkinides V, von Wschenbach AC, et al (2002). American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin, 52, 8-22. https://doi.org/10.3322/canjclin.52.1.8
- Sousa JF, Ham AJ, Whitwell C, et al (2012). Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers. Am J Pathol, 181, 1560-72. https://doi.org/10.1016/j.ajpath.2012.07.027
- Paul D, Kumar A, Gajbhiye A, Santra MK, Srikanth R (2013). Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. Biomed Res Int, 2013, 783131.
- Srinivas PR, Verma M, Zhao Y, Srivastava S (2002). Proteomics for cancer biomarker discovery. Clin Chem, 48, 1160-9.
- Stoevesandt O, Taussig MJ, He M (2009). Protein microarrays: high-throughput tools for proteomics. Expert Rev Proteomics, 6, 145-57. https://doi.org/10.1586/epr.09.2
- Strassberger V, Fugmann T, Neri D, Roesli C (2010). Chemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer. J Proteomics, 73, 1954-73. https://doi.org/10.1016/j.jprot.2010.05.018
- Sun W, Xing B, Sun Y, et al (2007). Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics, 6, 1798-808. https://doi.org/10.1074/mcp.M600449-MCP200
- Tan HT, Lee YH, Chung MC (2012). Cancer proteomics. Mass Spectrom Rev, 31, 583-605. https://doi.org/10.1002/mas.20356
- Thiviyanathan V, Gorenstein DG (2012). Aptamers and the next generation of diagnostic reagents. Proteomics Clin Appl, 6, 563-73. https://doi.org/10.1002/prca.201200042
- Uemura N, Nakanishi Y, Kato H, et al (2009). Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int J Cancer, 124, 2106-15. https://doi.org/10.1002/ijc.24194
- Varghese RS, Zhou B, Nezami Ranjbar MR, Zhao Y, Resson HW (2012). Ion annotation-assisted analysis of LC-MS based metabolomic experiment. Proteome Sci, 21, 1477-5956.
- Walther TC, Mann M (2010). Mass spectrometry-based proteomics in cell biology. J Cell Biol, 190, 491-500. https://doi.org/10.1083/jcb.201004052
- Wang J-J, Liu Y, Zheng Y (2012). Comparative proteomics analysis of colorectal cancer. Asian Pac J Cancer Prev, 13, 1663-6. https://doi.org/10.7314/APJCP.2012.13.4.1663
- Wang P, Whiteaker JR, Paulovich AG (2009). The evolving role of mass spectrometry in cancer biomarker discovery. Cancer Biol Ther, 8, 1083-94.
- Wu CC, Chen HC, Chen SJ, et al (2008). Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics, 8, 316-32. https://doi.org/10.1002/pmic.200700819
- Wulfkuhle JD, Liotta LA, Petriccoin EF (2003). Proteomic applications for the early detection of cancer. Nat Rev Cancer, 3, 267-75. https://doi.org/10.1038/nrc1043
- Wulfkuhle JD, Paweletz CP, Steeg PS, Petricoin EF 3rd, Liotta L (2003). Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv Exp Med Biol, 532, 59-68. https://doi.org/10.1007/978-1-4615-0081-0_7
- Xiao JF, Varghese RS, Zhou B, et al (2012). LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian Cohort. J Proteome Res, 11, 5914-23.
- Yanagisawa K, Tomida S Shimada Y, et al (2007). A 25-Signal proteomic signature and outcome for patients with resected non-small-cell lung cancer. J Natl Cancer Inst, 99, 858-67. https://doi.org/10.1093/jnci/djk197
- Yang F, Xiao ZQ, Zhang XZ, et al (2007). Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. J Proteome Res, 6, 751-8. https://doi.org/10.1021/pr0602287
- Yousefi Z, Sarvari J, Nakamura K, et al (2012). Secretomic analysis of large cell lung cancer cell lines using two-dimensional gel electrophoresis coupled to mass spectrometry. Folia Histochem Cytobiol, 50, 368-74. https://doi.org/10.5603/FHC.2012.0050
피인용 문헌
- Proteome–Metabolome Profiling of Ovarian Cancer Ascites Reveals Novel Components Involved in Intercellular Communication vol.13, pp.12, 2014, https://doi.org/10.1074/mcp.M114.041194
- Effects of Hypobaric Conditions on Apoptosis Signalling Pathways in HeLa Cells vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.5043
- Pemetrexed Induces G1 Phase Arrest and Apoptosis through Inhibiting Akt Activation in Human Non Small Lung Cancer Cell Line A549 vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1507
- Antioxidant, Anticancer and Anticholinesterase Activities of Flower, Fruit and Seed Extracts of Hypericum amblysepalum HOCHST vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2763
- Polycyclic aromatic hydrocarbons and childhood asthma vol.30, pp.2, 2015, https://doi.org/10.1007/s10654-015-9988-6